Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03396510 · ClinicalTrials.gov registry record · NA
Electronic Symptom Monitoring Intervention for Hospitalized Patients With Cancer
A NA study of Cancer, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 390
- Enrollment target
- 1
- Study location
NCT03396510: Completed NA study of Cancer, sponsored by Massachusetts General Hospital.
NCT03396510 is a NA study of Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 390 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03396510, a NA study of Cancer, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 390 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is evaluating a new way to deliver oncology care for patients with cancer
Primary Outcome
Using ESAS and PHQ symptoms, the investigators will compare the proportion of days that symptoms improved in standard care versus IMPROVED.
Conditions Studied
Interventions
- OTHER IMPROVED intervention
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2022-12-20 |
| Phase | NA |
What the finished NCT03396510 record still lists
NCT03396510 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which IMPROVED intervention is the first listed.
NCT03396510 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03396510 about?
NCT03396510 is a clinical study titled "Electronic Symptom Monitoring Intervention for Hospitalized Patients With Cancer". This research study is evaluating a new way to deliver oncology care for patients with cancer
What is the current status of trial NCT03396510?
This trial is currently completed. It is a NA study. The enrollment target is 390 participants. The study started on 2018-02-12. Estimated completion is 2022-12-20.
What conditions does trial NCT03396510 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT03396510?
The interventions under investigation include: IMPROVED intervention (OTHER).
Who is sponsoring clinical trial NCT03396510?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03396510 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03396510's enrollment target sits among peer trials
390 153rd of 615 higher than 462 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- NCT06132893 · 390 participants · Phase 2
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI